The DOI matches its Crossref record; 155 of the 155 references it cites were found in a registry or an index.
Breast Cancer
Open accessAbstract
NCCN Categories of Evidence and ConsensusCategory 1: The recommendation is based on high-level evidence (e.g., randomized controlled trials) and there is uniform NCCN consensus.Category 2A: The recommendation is based on lower-level evidence and there is uniform NCCN consensus. Category 2B:The recommendation is based on lower-level evidence and there is nonuniform NCCN consensus (but no major disagreement). Category 3: The recommendation is based on any level of OverviewThe American Cancer Society estimated that 184,450 new cases of invasive breast cancer would be diagnosed and 40,930 patients would die of the disease in the United States in 2008. 1 In addition, approximately 67,770 women will be diagnosed with carcinoma in situ of the breast during the same year.Breast cancer is the
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Slamon, D. J., Leyland-Jones, B., Shak, S., Fuchs, H., Paton, V., Bajamonde, A., Fleming, T., Eiermann, W., Wolter, J., Pegram, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200103153441101 · Cited by 11,500
A Gene-Expression Signature as a Predictor of Survival in Breast Cancer
van de Vijver, M. J., He, Y. D., van 't Veer, L. J., Dai, H., Hart, A. A. M., Voskuil, D. W., Schreiber, G. J., Peterse, J. L., Roberts, C., Marton, M. J., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021967 · Cited by 6,488
A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer
Paik, S., Shak, S., Tang, G., Kim, C., Baker, J., Cronin, M., Baehner, F. L., Walker, M. G., Watson, D., Park, T., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa041588 · Cited by 6,277
Fisher, B., Anderson, S., Bryant, J., Margolese, R. G., Deutsch, M., Fisher, E. R., Jeong, J.-H., & Wolmark, N. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa022152 · Cited by 6,249
Repeated observation of breast tumor subtypes in independent gene expression data sets
Sørlie, T., Tibshirani, R., Parker, J., Hastie, T., Marron, J. S., Nobel, A., Deng, S., Johnsen, H., Pesich, R., Geisler, S., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0932692100 · Cited by 5,429
Trastuzumab plus Adjuvant Chemotherapy for Operable HER2-Positive Breast Cancer
Romond, E. H., Perez, E. A., Bryant, J., Suman, V. J., Geyer, C. E., Davidson, N. E., Tan-Chiu, E., Martino, S., Paik, S., Kaufman, P. A., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa052122 · Cited by 5,356
Trastuzumab after Adjuvant Chemotherapy in HER2-Positive Breast Cancer
Piccart-Gebhart, M. J., Procter, M., Leyland-Jones, B., Goldhirsch, A., Untch, M., Smith, I., Gianni, L., Baselga, J., Bell, R., Jackisch, C., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa052306 · Cited by 5,084
Veronesi, U., Cascinelli, N., Mariani, L., Greco, M., Saccozzi, R., Luini, A., Aguilar, M., & Marubini, E. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020989 · Cited by 4,450
Wolff, A. C., Hammond, M. E. H., Schwartz, J. N., Hagerty, K. L., Allred, D. C., Cote, R. J., Dowsett, M., Fitzgibbons, P. L., Hanna, W. M., Langer, A., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.09.2775 · Cited by 4,434
Self-citationLapatinib plus Capecitabine for HER2-Positive Advanced Breast Cancer
Geyer, C. E., Forster, J., Lindquist, D., Chan, S., Romieu, C. G., Pienkowski, T., Jagiello-Gruszfeld, A., Crown, J., Chan, A., Kaufman, B., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa064320 · Cited by 3,425
Paclitaxel plus Bevacizumab versus Paclitaxel Alone for Metastatic Breast Cancer
Miller, K., Wang, M., Gralow, J., Dickler, M., Cobleigh, M., Perez, E. A., Shenkier, T., Cella, D., & Davidson, N. E. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa072113 · Cited by 3,081
Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer
Wang, Y., Klijn, J. G., Zhang, Y., Sieuwerts, A. M., Look, M. P., Yang, F., Talantov, D., Timmermans, M., Meijer-van Gelder, M. E., Yu, J., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)17947-1 · Cited by 2,846
Cobleigh, M. A., Vogel, C. L., Tripathy, D., Robert, N. J., Scholl, S., Fehrenbacher, L., Wolter, J. M., Paton, V., Shak, S., Lieberman, G., et al. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.9.2639 · Cited by 2,765
Paik, S., Tang, G., Shak, S., Kim, C., Baker, J., Kim, W., Cronin, M., Baehner, F. L., Watson, D., Bryant, J., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.7985 · Cited by 2,579
A Randomized Comparison of Sentinel-Node Biopsy with Routine Axillary Dissection in Breast Cancer
Veronesi, U., Paganelli, G., Viale, G., Luini, A., Zurrida, S., Galimberti, V., Intra, M., Veronesi, P., Robertson, C., Maisonneuve, P., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa012782 · Cited by 2,210
Effect of preoperative chemotherapy on the outcome of women with operable breast cancer.
Fisher, B., Bryant, J., Wolmark, N., Mamounas, E., Brown, A., Fisher, E. R., Wickerham, D. L., Begovic, M., DeCillis, A., Robidoux, A., et al. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.8.2672 · Cited by 2,165
Prognostic and predictive factors in breast cancer by immunohistochemical analysis.
Allred, D. C., Harvey, J. M., Berardo, M. D., & Gm, C. (1998) · PubMed · Cited by 2,143
Self-citationThe Sentinel Node in Breast Cancer — A Multicenter Validation Study
Krag, D., Weaver, D., Ashikaga, T., Moffat, F., Klimberg, V. S., Shriver, C., Feldman, S., Kusminsky, R., Gadd, M., Kuhn, J., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199810013391401 · Cited by 2,018
Lyman, G. H., Giuliano, A. E., Somerfield, M. R., Benson, A. B., Bodurka, D. C., Burstein, H. J., Cochran, A. J., Cody, H. S., Edge, S. B., Galper, S., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.08.001 · Cited by 1,887
Self-citationVogel, C. L., Cobleigh, M. A., Tripathy, D., Gutheil, J. C., Harris, L. N., Fehrenbacher, L., Slamon, D. J., Murphy, M., Novotny, W. F., Burchmore, M., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.20.3.719 · Cited by 1,860
Risk Factors for Breast Cancer in Women with Proliferative Breast Disease
Dupont, W. D., & Page, D. L. (1985) · New England Journal of Medicine · doi:10.1056/nejm198501173120303 · Cited by 1,829
Wolff, A. C., Hammond, M. E. H., Schwartz, J. N., Hagerty, K. L., Allred, D. C., Cote, R. J., Dowsett, M., Fitzgibbons, P. L., Hanna, W. M., Langer, A., et al. (2007) · Archives of Pathology & Laboratory Medicine · doi:10.5858/2007-131-18-asocco · Cited by 1,816
Self-citationMansel, R. E., Fallowfield, L., Kissin, M., Goyal, A., Newcombe, R. G., Dixon, J. M., Yiangou, C., Horgan, K., Bundred, N., Monypenny, I., et al. (2006) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djj158 · Cited by 1,679
Overgaard, M., Jensen, M.-B., Overgaard, J., Hansen, P. S., Rose, C., Andersson, M., Kamby, C., Kjaer, M., Gadeberg, C. C., Rasmussen, B. B., et al. (1999) · The Lancet · doi:10.1016/s0140-6736(98)09201-0 · Cited by 1,602
A Comparison of Letrozole and Tamoxifen in Postmenopausal Women with Early Breast Cancer
(2005) · New England Journal of Medicine · doi:10.1056/nejmoa052258 · Cited by 1,577
Cardiac Dysfunction in the Trastuzumab Clinical Trials Experience
Seidman, A. D., Hudis, C. A., Pierri, M. K., Shak, S., Paton, V. E., Ashby, M. A., Murphy, M., Stewart, S. J., & Keefe, D. L. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.5.1215 · Cited by 1,563
Self-citationAdjuvant Docetaxel or Vinorelbine with or without Trastuzumab for Breast Cancer
Joensuu, H., Kellokumpu-Lehtinen, P.-L., Bono, P., Alanko, T., Kataja, V., Asola, R., Utriainen, T., Kokko, R., Hemminki, A., Tarkkanen, M., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa053028 · Cited by 1,403
Distinctive gene expression patterns in human mammary epithelial cells and breast cancers
Perou, C. M., Jeffrey, S. S., van de Rijn, M., Rees, C. A., Eisen, M. B., Ross, D. T., Pergamenschikov, A., Williams, C. F., Zhu, S. X., Lee, J. C. F., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.16.9212 · Cited by 1,402
Fisher, B., Redmond, C., Fisher, E. R., Bauer, M., Wolmark, N., Wickerham, D. L., Deutsch, M., Montague, E., Margolese, R., & Foster, R. (1985) · New England Journal of Medicine · doi:10.1056/nejm198503143121102 · Cited by 1,376
Concordance among Gene-Expression–Based Predictors for Breast Cancer
Fan, C., Oh, D. S., Wessels, L., Weigelt, B., Nuyten, D. S. A., Nobel, A. B., van't Veer, L. J., & Perou, C. M. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa052933 · Cited by 1,341
Buzdar, A. U., Ibrahim, N. K., Francis, D., Booser, D. J., Thomas, E. S., Theriault, R. L., Pusztai, L., Green, M. C., Arun, B. K., Giordano, S. H., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.07.032 · Cited by 1,171
Self-citationGoss, P. E., Ingle, J. N., Martino, S., Robert, N. J., Muss, H. B., Piccart, M. J., Castiglione, M., Tu, D., Shepherd, L. E., Pritchard, K. I., et al. (2005) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dji250 · Cited by 1,118
O’Shaughnessy, J., Miles, D., Vukelja, S., Moiseyenko, V., Ayoub, J.-P., Cervantes, G., Fumoleau, P., Jones, S., Lui, W.-Y., Mauriac, L., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.09.002 · Cited by 1,081
Hughes, K. S., Schnaper, L. A., Berry, D., Cirrincione, C., McCormick, B., Shank, B., Wheeler, J., Champion, L. A., Smith, T. J., Smith, B. L., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040587 · Cited by 1,078
Self-citationEllis, M. J., Coop, A., Singh, B., Mauriac, L., Llombert-Cussac, A., Jänicke, F., Miller, W. R., Evans, D. B., Dugan, M., Brady, C., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.18.3808 · Cited by 1,060
Ragaz, J., Olivotto, I. A., Spinelli, J. J., Phillips, N., Jackson, S. M., Wilson, K. S., Knowling, M. A., Coppin, C. M. L., Weir, L., Gelmon, K., et al. (2005) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh297 · Cited by 1,027
Hortobagyi, G. N., Theriault, R. L., Porter, L., Blayney, D., Lipton, A., Sinoff, C., Wheeler, H., Simeone, J. F., Seaman, J., Knight, R. D., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199612123352401 · Cited by 1,026
Self-citationWeekly Paclitaxel in the Adjuvant Treatment of Breast Cancer
Sparano, J. A., Wang, M., Martino, S., Jones, V., Perez, E. A., Saphner, T., Wolff, A. C., Sledge, G. W., Wood, W. C., & Davidson, N. E. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0707056 · Cited by 997
Self-citationRavdin, P. M., Siminoff, L. A., Davis, G. J., Mercer, M. B., Hewlett, J., Gerson, N., & Parker, H. L. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.4.980 · Cited by 996
Nabholtz, J. M., Buzdar, A., Pollak, M., Harwin, W., Burton, G., Mangalik, A., Steinberg, M., Webster, A., & von Euler, M. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.22.3758 · Cited by 992
Hillner, B. E., Ingle, J. N., Chlebowski, R. T., Gralow, J., Yee, G. C., Janjan, N. A., Cauley, J. A., Blumenstein, B. A., Albain, K. S., Lipton, A., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.08.017 · Cited by 970
Adjuvant Docetaxel for Node-Positive Breast Cancer
Martin, M., Pienkowski, T., Mackey, J., Pawlicki, M., Guastalla, J.-P., Weaver, C., Tomiak, E., Al-Tweigeri, T., Chap, L., Juhos, E., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043681 · Cited by 954
Jin, Y., Desta, Z., Stearns, V., Ward, B., Ho, H., Lee, K.-H., Skaar, T., Storniolo, A. M., Li, L., Araba, A., et al. (2005) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dji005 · Cited by 951
Self-citationBartelink, H., Horiot, J.-C., Poortmans, P., Struikmans, H., Van den Bogaert, W., Barillot, I., Fourquet, A., Borger, J., Jager, J., Hoogenraad, W., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa010874 · Cited by 941
Rosen, L. S., Gordon, D., Kaminski, M., Howell, A., Belch, A. R., Mackey, J. R., Apffelstaedt, J., Hussein, M., Coleman, R. E., Reitsma, D. J., et al. (2001) · PubMed · Cited by 896
Bast, R. C., Ravdin, P., Hayes, D. F., Bates, S., Fritsche, H., Jessup, J. M., Kemeny, N., Locker, G. Y., Mennel, R. G., & Somerfield, M. R. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.6.1865 · Cited by 879
Self-citationBonneterre, J., Thürlimann, B., Robertson, J. F. R., Krzakowski, M., Mauriac, L., Koralewski, P., Vergote, I., Webster, A., Steinberg, M., & von Euler, M. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.22.3748 · Cited by 842
Houssami, N., Ciatto, S., Macaskill, P., Lord, S. J., Warren, R. M., Dixon, J. M., & Irwig, L. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.2108 · Cited by 831
Tan-Chiu, E., Yothers, G., Romond, E., Geyer, C. E., Ewer, M., Keefe, D., Shannon, R. P., Swain, S. M., Brown, A., Fehrenbacher, L., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.02.4091 · Cited by 808
Smith, I. E., Dowsett, M., Ebbs, S. R., Dixon, J. M., Skene, A., Blohmer, J.-U., Ashley, S. E., Francis, S., Boeddinghaus, I., & Walsh, G. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.005 · Cited by 774
Loprinzi, C. L., Kugler, J. W., Sloan, J. A., Mailliard, J. A., LaVasseur, B. I., Barton, D. L., Novotny, P. J., Dakhil, S. R., Rodger, K., Rummans, T. A., et al. (2000) · The Lancet · doi:10.1016/s0140-6736(00)03403-6 · Cited by 737
Berry, D. A., Cirrincione, C., Henderson, I. C., Citron, M. L., Budman, D. R., Goldstein, L. J., Martino, S., Perez, E. A., Muss, H. B., Norton, L., et al. (2006) · JAMA · doi:10.1001/jama.295.14.1658 · Cited by 731
Self-citationINTERNATIONALCOLLABORATIVEHYPERT, VERNON, C., HAND, J., FIELD, S., MACHIN, D., WHALEY, J., ZEE, J., VANPUTTEN, W., VANRHOON, G., & VANDIJK, J. (1996) · International Journal of Radiation OncologyBiologyPhysics · doi:10.1016/0360-3016(96)00154-x · Cited by 725
Sledge, G. W., Neuberg, D., Bernardo, P., Ingle, J. N., Martino, S., Rowinsky, E. K., & Wood, W. C. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.08.013 · Cited by 707
Hance, K. W., Anderson, W. F., Devesa, S. S., Young, H. A., & Levine, P. H. (2005) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dji172 · Cited by 689
Matese, J. C., Sørlie, T., Tibshirani, R., Jeffrey, S. S., Johnsen, H., Brown, P. O., Lønning, P. E., Quist, H., Botstein, D., Eisen, M. B., et al. (2020) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/qpxp-y103 · Cited by 679
Howell, A., Robertson, J. F. R., Quaresma Albano, J., Aschermannova, A., Mauriac, L., Kleeberg, U. R., Vergote, I., Erikstein, B., Webster, A., & Morris, C. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.10.057 · Cited by 671
Weighing the Risks and Benefits of Tamoxifen Treatment for Preventing Breast Cancer
Gail, M. H., Costantino, J. P., Bryant, J., Croyle, R., Freedman, L., Helzlsouer, K., & Vogel, V. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.21.1829 · Cited by 670
Fyles, A. W., McCready, D. R., Manchul, L. A., Trudeau, M. E., Merante, P., Pintilie, M., Weir, L. M., & Olivotto, I. A. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040595 · Cited by 651
Dombernowsky, P., Smith, I., Falkson, G., Leonard, R., Panasci, L., Bellmunt, J., Bezwoda, W., Gardin, G., Gudgeon, A., Morgan, M., et al. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.2.453 · Cited by 638
Hortobagyi, G. N., Theriault, R. L., Lipton, A., Porter, L., Blayney, D., Sinoff, C., Wheeler, H., Simeone, J. F., Seaman, J. J., Knight, R. D., et al. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.6.2038 · Cited by 631
Self-citationArriagada, R., Lê, M. G., Rochard, F., & Contesso, G. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.5.1558 · Cited by 612
erbB-2, p53, and Efficacy of Adjuvant Therapy in Lymph Node-Positive Breast Cancer
Thor, A. D., Berry, D. A., Budman, D. R., Muss, H. B., Kute, T., Henderson, I. C., Barcos, M., Cirrincione, C., Edgerton, S., Allred, C., et al. (1998) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/90.18.1346 · Cited by 612
Theriault, R. L., Lipton, A., Hortobagyi, G. N., Leff, R., Glück, S., Stewart, J. F., Costello, S., Kennedy, I., Simeone, J., Seaman, J. J., et al. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.3.846 · Cited by 604
Self-citationRoché, H., Fumoleau, P., Spielmann, M., Canon, J.-L., Delozier, T., Serin, D., Symann, M., Kerbrat, P., Soulié, P., Eichler, F., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.07.3916 · Cited by 577
Population-Based Validation of the Prognostic Model ADJUVANT! for Early Breast Cancer
Olivotto, I. A., Bajdik, C. D., Ravdin, P. M., Speers, C. H., Coldman, A. J., Norris, B. D., Davis, G. J., Chia, S. K., & Gelmon, K. A. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.06.178 · Cited by 567
Randomized Trial of Hyperthermia and Radiation for Superficial Tumors
Jones, E. L., Oleson, J. R., Prosnitz, L. R., Samulski, T. V., Vujaskovic, Z., Yu, D., Sanders, L. L., & Dewhirst, M. W. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.05.520 · Cited by 560
Chia, S., Gradishar, W., Mauriac, L., Bines, J., Amant, F., Federico, M., Fein, L., Romieu, G., Buzdar, A., Robertson, J. F. R., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.13.5822 · Cited by 513
Self-citationHER2 and Responsiveness of Breast Cancer to Adjuvant Chemotherapy
Pritchard, K. I., Shepherd, L. E., O'Malley, F. P., Andrulis, I. L., Tu, D., Bramwell, V. H., & Levine, M. N. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa054504 · Cited by 509
Fourquet, A., Campana, F., Zafrani, B., Mosseri, V., Vielh, P., Durand, J.-C., & Vilcoq, J. R. (1989) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(89)90057-6 · Cited by 509
Intensive Diagnostic Follow-up After Treatment of Primary Breast Cancer: A Randomized Trial
Del Turco, M. R. (1994) · JAMA · doi:10.1001/jama.1994.03510440053032 · Cited by 497
Converting a breast cancer microarray signature into a high-throughput diagnostic test
Glas, A. M., Floore, A., Delahaye, L. J., Witteveen, A. T., Pover, R. C., Bakx, N., Lahti-Domenici, J. S., Bruinsma, T. J., Warmoes, M. O., Bernards, R., et al. (2006) · BMC Genomics · doi:10.1186/1471-2164-7-278 · Cited by 494
Paik, S., Bryant, J., Tan-Chiu, E., Romond, E., Hiller, W., Park, K., Brown, A., Yothers, G., Anderson, S., Smith, R., et al. (2002) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/94.11.852 · Cited by 484
Thomas, E. S., Gomez, H. L., Li, R. K., Chung, H.-C., Fein, L. E., Chan, V. F., Jassem, J., Pivot, X. B., Klimovsky, J. V., de Mendoza, F. H., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.12.6557 · Cited by 481
Robert, N., Leyland-Jones, B., Asmar, L., Belt, R., Ilegbodu, D., Loesch, D., Raju, R., Valentine, E., Sayre, R., Cobleigh, M., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.1764 · Cited by 479
Dowsett, M., Allred, C., Knox, J., Quinn, E., Salter, J., Wale, C., Cuzick, J., Houghton, J., Williams, N., Mallon, E., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.12.9437 · Cited by 450
Recht, A., Come, S. E., Henderson, I. C., Gelman, R. S., Silver, B., Hayes, D. F., Shulman, L. N., & Harris, J. R. (1996) · New England Journal of Medicine · doi:10.1056/nejm199605233342102 · Cited by 436
Self-citationKlijn, J. G. M., Blamey, R. W., Boccardo, F., Tominaga, T., Duchateau, L., & Sylvester, R. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.2.343 · Cited by 425
Buzdar, A. U., Jonat, W., Howell, A., Jones, S. E., BLOMQVIST, C. P., Vogel, C. L., EIERMANN, W., Wolter, J. M., Steinberg, M., Webster, A., et al. (1998) · PubMed · Cited by 417
Perez, E. A., Lerzo, G., Pivot, X., Thomas, E., Vahdat, L., Bosserman, L., Viens, P., Cai, C., Mullaney, B., Peck, R., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.09.3849 · Cited by 393
Rapiti, E., Verkooijen, H. M., Vlastos, G., Fioretta, G., Neyroud-Caspar, I., Sappino, A. P., Chappuis, P. O., & Bouchardy, C. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.2226 · Cited by 391
Does aggressive local therapy improve survival in metastatic breast cancer?
Khan, S. A., Stewart, A. K., & Morrow, M. (2002) · Surgery · doi:10.1067/msy.2002.127544 · Cited by 391
Concordance Between Local and Central Laboratory HER2 Testing in the Breast Intergroup Trial N9831
Roche, P. C., Suman, V. J., Jenkins, R. B., Davidson, N. E., Martino, S., Kaufman, P. A., Addo, F. K., Murphy, B., Ingle, J. N., & Perez, E. A. (2002) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/94.11.855 · Cited by 390
Buzdar, A., Douma, J., Davidson, N., Elledge, R., Morgan, M., Smith, R., Porter, L., Nabholtz, J., Xiang, X., & Brady, C. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.14.3357 · Cited by 365
Solin, L. J., Orel, S. G., Hwang, W.-T., Harris, E. E., & Schnall, M. D. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2006.09.5448 · Cited by 346
Wahl, R. L., Siegel, B. A., Coleman, R. E., & Gatsonis, C. G. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.04.148 · Cited by 345
Inflammatory breast cancer: a review.
Jaiyesimi, I. A., Buzdar, A. U., & Hortobagyi, G. (1992) · Journal of Clinical Oncology · doi:10.1200/jco.1992.10.6.1014 · Cited by 341
De Laurentiis, M., Arpino, G., Massarelli, E., Ruggiero, A., Carlomagno, C., Ciardiello, F., Tortora, G., D'Agostino, D., Caputo, F., Cancello, G., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-2569 · Cited by 340
Rosen, L. S., Gordon, D. H., Dugan, W., Major, P., Eisenberg, P. D., Provencher, L., Kaminski, M., Simeone, J., Seaman, J., Chen, B., et al. (2004) · Cancer · doi:10.1002/cncr.11892 · Cited by 335
Lønning, P. E., Bajetta, E., Murray, R., Tubiana-Hulin, M., Eisenberg, P. D., Mickiewicz, E., Celio, L., Pitt, P., Mita, M., Aaronson, N. K., et al. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.11.2234 · Cited by 316
Press, M. F., Sauter, G., Bernstein, L., Villalobos, I. E., Mirlacher, M., Zhou, J.-Y., Wardeh, R., Li, Y.-T., Guzman, R., Ma, Y., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0636 · Cited by 311
Single agent versus combination chemotherapy for metastatic breast cancer
Carrick, S., Parker, S., Thornton, C., Ghersi, D., Simes, J., & Wilcken, N. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003372.pub3 · Cited by 305
Paik, S. (2000) · Journal of the National Cancer Institute · doi:10.1093/jnci/92.24.1991 · Cited by 304
Sentinel-Lymph-Node Biopsy for Breast Cancer — Not Yet the Standard of Care
McMasters, K. M., Giuliano, A. E., Ross, M. I., Reintgen, D. S., Hunt, K. K., Byrd, D. R., Klimberg, V. S., Whitworth, P. W., Tafra, L. C., & Edwards, M. J. (1998) · New England Journal of Medicine · doi:10.1056/nejm199810013391410 · Cited by 299
Comparative Study of Surgical Margins in Oncoplastic Surgery and Quadrantectomy in Breast Cancer
Kaur, N., Petit, J.-Y., Rietjens, M., Maffini, F., Luini, A., Gatti, G., Rey, P. C., Urban, C., & De Lorenzi, F. (2005) · Annals of Surgical Oncology · doi:10.1245/aso.2005.12.046 · Cited by 290
Thomas, E., Tabernero, J., Fornier, M., Conté, P., Fumoleau, P., Lluch, A., Vahdat, L. T., Bunnell, C. A., Burris, H. A., Viens, P., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.08.9102 · Cited by 290
Babiera, G. V., Rao, R., Feng, L., Meric-Bernstam, F., Kuerer, H. M., Singletary, S. E., Hunt, K. K., Ross, M. I., Gwyn, K. M., Feig, B. W., et al. (2006) · Annals of Surgical Oncology · doi:10.1245/aso.2006.03.033 · Cited by 284
Conte, P. F., Latreille, J., Mauriac, L., Calabresi, F., Santos, R., Campos, D., Bonneterre, J., Francini, G., & Ford, J. M. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.9.2552 · Cited by 268
Kaufmann, M., Jonat, W., Hilfrich, J., Eidtmann, H., Gademann, G., Zuna, I., & von Minckwitz, G. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.08.8054 · Cited by 267
FDG PET, PET/CT, and Breast Cancer Imaging
Rosen, E. L., Eubank, W. B., & Mankoff, D. A. (2007) · RadioGraphics · doi:10.1148/rg.27si075517 · Cited by 265
Her-2/neu as a Predictive Marker of Response to Breast Cancer Therapy
Pegram, M. D., Pauletti, G., & Slamon, D. J. (1998) · Breast Cancer Research and Treatment · doi:10.1023/a:1006111117877 · Cited by 259
Association of Surgery With Improved Survival in Stage IV Breast Cancer Patients
Blanchard, D. K., Shetty, P. B., Hilsenbeck, S. G., & Elledge, R. M. (2008) · Annals of Surgery · doi:10.1097/sla.0b013e3181656d32 · Cited by 254
Smith, T. J., Davidson, N. E., Schapira, D. V., Grunfeld, E., Muss, H. B., Vogel, V. G., & Somerfield, M. R. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.3.1080 · Cited by 252
Clinicopathologic factors associated with false negative FDG–PET in primary breast cancer
Kumar, R., Chauhan, A., Zhuang, H., Chandra, P., Schnall, M., & Alavi, A. (2006) · Breast Cancer Research and Treatment · doi:10.1007/s10549-006-9159-2 · Cited by 226
Roché, H., Yelle, L., Cognetti, F., Mauriac, L., Bunnell, C., Sparano, J., Kerbrat, P., Delord, J.-P., Vahdat, L., Peck, R., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.09.7535 · Cited by 224
Levine, M. N., Pritchard, K. I., Bramwell, V. H. C., Shepherd, L. E., Tu, D., & Paul, N. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.09.423 · Cited by 220
Burstein, H. J., Keshaviah, A., Baron, A. D., Hart, R. D., Lambert‐Falls, R., Marcom, P. K., Gelman, R., & Winer, E. P. (2007) · Cancer · doi:10.1002/cncr.22885 · Cited by 214
Self-citationHER2 Testing in Breast Cancer: NCCN Task Force Report and Recommendations
Carlson, R. W., Moench, S. J., Hammond, M. E. H., Perez, E. A., Burstein, H. J., Allred, D. C., Vogel, C. L., Goldstein, L. J., Somlo, G., Gradishar, W. J., et al. (2006) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2006.2003 · Cited by 205
Self-citationEstimating the magnitude of trastuzumab effects within patient subgroups in the HERA trial
Untch, M., Gelber, R. D., Jackisch, C., Procter, M., Baselga, J., Bell, R., Cameron, D., Bari, M., Smith, I., Leyland-Jones, B., et al. (2008) · Annals of Oncology · doi:10.1093/annonc/mdn005 · Cited by 197
Antonini, N., Jones, H., Horiot, J. C., Poortmans, P., Struikmans, H., den Bogaert, W. V., Barillot, I., Fourquet, A., Jager, J., Hoogenraad, W., et al. (2007) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2006.09.014 · Cited by 185
Berry, D. A., Muss, H. B., Thor, A. D., Dressler, L., Liu, E. T., Broadwater, G., Budman, D. R., Henderson, I. C., Barcos, M., Hayes, D., et al. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.20.3471 · Cited by 180
Self-citationWang, S., Saboorian, M. H., Frenkel, E., Hynan, L., Gokaslan, S. T., & Ashfaq, R. (2000) · Journal of Clinical Pathology · doi:10.1136/jcp.53.5.374 · Cited by 180
Diel, I. J., Body, J.-J., Lichinitser, M. R., Kreuser, E. D., Dornoff, W., Gorbunova, V. A., Budde, M., & Bergström, B. (2004) · European Journal of Cancer · doi:10.1016/j.ejca.2004.03.025 · Cited by 166
Paik, S., Tang, G., Shak, S., Kim, C., Baker, J. B., Kim, W., Cronin, M. T., Baehner, F. L., Watson, D., Bryant, J., et al. (2023) · Journal of Clinical Oncology · doi:10.1200/jco.22.02570 · Cited by 156
Capecitabine and Trastuzumab in Heavily Pretreated Metastatic Breast Cancer
Bartsch, R., Wenzel, C., Altorjai, G., Pluschnig, U., Rudas, M., Mader, R. M., Gnant, M., Zielinski, C. C., & Steger, G. G. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.11.9776 · Cited by 150
Wilkinson, G. S., Kuo, Y., Freeman, J. L., & Goodwin, J. S. (2007) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djm025 · Cited by 149
Kroman, N. T., Holtveg, H., Wohlfahrt, J., Jensen, M., Mouridsen, H. T., Blichert-Toft, M., & Melbye, M. (2004) · Cancer · doi:10.1002/cncr.20022 · Cited by 146
Ingle, J. N., Suman, V. J., Rowland, K. M., Mirchandani, D., Bernath, A. M., Camoriano, J. K., Fishkin, P. A. S., Nikcevich, D. A., & Perez, E. A. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.1053 · Cited by 144
Stopping Metastases at Their Source
Hellmän, S. (1997) · New England Journal of Medicine · doi:10.1056/nejm199710023371408 · Cited by 141
Kirova, Y. M., Stoppa-Lyonnet, D., Savignoni, A., Sigal-Zafrani, B., Fabre, N., & Fourquet, A. (2005) · European Journal of Cancer · doi:10.1016/j.ejca.2005.02.037 · Cited by 129
Knoop, A. S., Bentzen, S. M., Nielsen, M. M., Rasmussen, B., & Rose, C. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.14.3376 · Cited by 122
Efficacy of Anastrozole in Male Breast Cancer
Giordano, S. H., Valero, V., Buzdar, A. U., & Hortobágyi, G. N. (2002) · American Journal of Clinical Oncology · doi:10.1097/00000421-200206000-00006 · Cited by 119
Single agent versus combination chemotherapy for metastatic breast cancer
Carrick, S. E., Parker, S., Thornton, C. E., Ghersi, D., Simes, J. R., & Wilcken, N. (2005) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003372.pub2 · Cited by 118
Swain, S. M., Wilson, J. W., Mamounas, E. P., Bryant, J., Wickerham, D. L., Fisher, B., Paik, S., & Wolmark, N. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh097 · Cited by 100
Understanding the Utility of Adjuvant Systemic Therapy for Primary Breast Cancer
Loprinzi, C. L., & Thomé, S. D. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.4.972 · Cited by 95
Falkson, G., Gelman, R. S., Pandya, K. J., Osborne, C. K., Tormey, D. C., Cummings, F. J., Sledge, G. W., & Abeloff, M. D. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.5.1669 · Cited by 92
The role of HER-2 expression in predicting response to therapy in breast cancer.
MASS, R. D. (2000) · PubMed · Cited by 92
Safety and Efficacy of Bisphosphonates Beyond 24 Months in Cancer Patients
Ali, S. M., Esteva, F. J., Hortobágyi, G. N., Harvey, H., Seaman, J. J., Knight, R., Costa, L., & Lipton, A. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.14.3434 · Cited by 91
Compliance with breast‐conservation standards for patients with early‐stage breast carcinoma
White, J. R., Morrow, M., Moughan, J., Owen, J. B., Pajak, T. F., DesHarnais, S., Winchester, D. P., & Wilson, J. F. (2003) · Cancer · doi:10.1002/cncr.11141 · Cited by 89
Increased incidence of ERBB2 overexpression and TP53 mutation in inflammatory breast cancer
Turpin, E., Bièche, I., Bertheau, P., Plassa, L., Lerebours, F., de Roquancourt, A., Olivi, M., Espié, M., Marty, M. E., Lidereau, R., et al. (2002) · Oncogene · doi:10.1038/sj.onc.1205932 · Cited by 87
Kuehn, T., Vogl, F. D., Helms, G., Pueckler, S. V., Schirrmeister, H., Strueber, R., Koretz, K., & Kreienberg, R. (2003) · European Journal of Surgical Oncology · doi:10.1016/j.ejso.2003.11.016 · Cited by 85
Danish Breast Cancer Cooperative Group--DBCG.
Fischerman, K., & Ht, M. (1977) · PubMed · Cited by 83
Molecular Heterogeneity of Inflammatory Breast Cancer: A Hyperproliferative Phenotype
Nguyen, D., Sam, K., Tsimelzon, A. I., Li, X., Wong, H. H., Mohsin, S. K., Clark, G. M., Hilsenbeck, S. G., Elledge, R. M., Allred, D. C., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-2248 · Cited by 82
Self-citationPrognostic and Predictive Significance of ErbB-2 Breast Tumor Levels Measured by Enzyme Immunoassay
Eppenberger‐Castori, S., Kueng, W., Benz, C. C., Caduff, R. F., Varga, Z., Bannwart, F., Fink, D., Dieterich, H., Höhl, M., Müller, H., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.3.645 · Cited by 81
von Minckwitz, G., Zielinski, C., Maarteense, E., Vogel, P., Schmidt, M., Eidtmann, H., Čufer, T., de Jongh, F. E., Kaufmann, M., & Loibl, S. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.26.15_suppl.1025 · Cited by 76
Genomics-Based Prognosis and Therapeutic Prediction in Breast Cancer
Jeffrey, S. S., Lønning, P. E., & Hillner, B. E. (2005) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2005.0016 · Cited by 58
Concordance with Breast Cancer Pathology Reporting Practice Guidelines
Wilkinson, N. W., Shahryarinejad, A., Winston, J. S., Watroba, N., & Edge, S. B. (2003) · Journal of the American College of Surgeons · doi:10.1016/s1072-7515(02)01627-7 · Cited by 58
Self-citationWeekly Paclitaxel in the Adjuvant Treatment of Breast Cancer
(2008) · New England Journal of Medicine · doi:10.1056/nejmx080020 · Cited by 47
Oncoplastic Breast Surgery: A Global Perspective on Practice, Availability, and Training
Malycha, P. L., Gough, I. R., Margaritoni, M., et al. (2008) · World Journal of Surgery · doi:10.1007/s00268-008-9635-4 · Cited by 44
Therapeutic options in the management of metastatic breast cancer.
Higgins, M. J., & Wolff, A. C. (2008) · PubMed · Cited by 43
Self-citationMorrow, M. (2006) · Yearbook of Oncology · doi:10.1016/s1040-1741(08)70037-x · Cited by 42
Kim, T., Lau, J., & Erban, J. K. (2006) · Clinical Breast Cancer · doi:10.3816/cbc.2006.n.055 · Cited by 41
Self-citationBerry, D. A., Cirrincione, C., Henderson, I. C., Citron, M. L., Budman, D. R., Goldstein, L. J., Martino, S., Perez, E. A., Muss, H. B., Norton, L., et al. (2006) · Obstetrical & Gynecological Survey · doi:10.1097/01.ogx.0000234789.05150.7c · Cited by 39
Self-citationBuzdar, A. U. (2005) · Breast Diseases A Year Book Quarterly · doi:10.1016/s1043-321x(05)80235-8 · Cited by 37
Vergote, I. B., Bonneterre, J. M., Thurlimann, B. J. K., et al. (2000) · European Journal of Cancer · doi:10.1016/s0959-8049(00)00239-2 · Cited by 34
Golshan, M. A., Miron, A., Nixon, A. J., Garber, J. E., Cash, E. P., Iglehart, J. D., Harris, J. R., & Wong, J. S. (2006) · The American Journal of Surgery · doi:10.1016/j.amjsurg.2005.12.005 · Cited by 33
Huo, L. (2007) · Breast Diseases A Year Book Quarterly · doi:10.1016/s1043-321x(07)80049-x · Cited by 31
What progress have we made in managing inflammatory breast cancer?
Dawood, S. S., & Cristofanilli, M. (2007) · PubMed · Cited by 30
NCCN Task Force Report: Bone Health and Cancer Care
Theriault, R. L., Biermann, J. S., Brown, E., Brufsky, A., Demers, L. M., Grewal, R. K., Guise, T. A., Jackson, R. D., McEnery, K. W., Podoloff, D. A., et al. (2006) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2006.2002 · Cited by 30
Self-citationSmith, B. D. (2007) · Breast Diseases A Year Book Quarterly · doi:10.1016/s1043-321x(07)80072-5 · Cited by 10
Powell, S. N. (2006) · Breast Diseases A Year Book Quarterly · doi:10.1016/s1043-321x(06)80482-0 · Cited by 4
Locally Advanced Breast Cancer
Brewster, A. M., & Hortobágyi, G. N. (2009) · Elsevier eBooks · doi:10.1016/b978-1-4160-5221-0.00072-3 · Cited by 4
Berenson (2001) · doi:10.1002/1097-0142(20010401)91:7<1191::aid-cncr1119>3.0.co;2-0
Cited by
Adjuvant Exemestane with Ovarian Suppression in Premenopausal Breast Cancer
Pagani, O., Regan, M. M., Walley, B. A., Fleming, G. F., Colleoni, M., Láng, I., Gomez, H. L., Tondini, C., Burstein, H. J., Perez, E. A., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1404037 · Cited by 749
Self-citationFilipits, M., Rudas, M., Jakesz, R., Dubsky, P., Fitzal, F., Singer, C. F., Dietze, O., Greil, R., Jelen, A., Sevelda, P., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-0926 · Cited by 733
Schnipper, L. E., Smith, T. J., Raghavan, D., Blayney, D. W., Ganz, P. A., Mulvey, T. M., & Wollins, D. S. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2012.42.8375 · Cited by 649
Houssami, N., Macaskill, P., Luke Marinovich, M., & Morrow, M. (2014) · Annals of Surgical Oncology · doi:10.1245/s10434-014-3480-5 · Cited by 532
Peppercorn, J. M., Smith, T. J., Helft, P. R., DeBono, D. J., Berry, S. R., Wollins, D. S., Hayes, D. M., Von Roenn, J. H., & Schnipper, L. E. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.33.1744 · Cited by 524
Self-citation
Metadata
- Authors
- Carlson, R. W., Allred, D. C., Anderson, B. O., Burstein, H. J., Carter, W. B., Edge, S. B., Erban, J. K., Farrar, W. B., Goldstein, L. J., Gradishar, W. J., Hayes, D. F., Hudis, C. A., Jahanzeb, M., Kiel, K., Ljung, B.-M., Marcom, P. K., Mayer, I. A., McCormick, B., Nabell, L. M., Pierce, L. J., Reed, E. C., Smith, M. L., Somlo, G., Theriault, R. L., Topham, N. S., Ward, J. H., Winer, E. P., & Wolff, A. C.
- Venue
- Journal of the National Comprehensive Cancer Network
- Publisher
- Harborside Press, LLC
- Published
- 2009-02
- Volume
- 7
- Issue
- 2
- Pages
- 122-192
- ISSN
- 1540-1405 (ISSN-L)
- 1540-1413
- OpenAlex
- W2311660836
- Cited by
- 450
- References
- 155
- FWCI
- 14.38
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.